Global Cancer Genome Sequencing Market Size, Status and Forecast 2024-2031

Report ID: 954677 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Second Generation
        1.2.3 Third Generation
    1.3 Market by Application
        1.3.1 Global Cancer Genome Sequencing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Treatment
        1.3.3 Research
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Genome Sequencing Market Perspective (2016-2027)
    2.2 Cancer Genome Sequencing Growth Trends by Regions
        2.2.1 Cancer Genome Sequencing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cancer Genome Sequencing Historic Market Share by Regions (2016-2021)
        2.2.3 Cancer Genome Sequencing Forecasted Market Size by Regions (2022-2027)
    2.3 Cancer Genome Sequencing Industry Dynamic
        2.3.1 Cancer Genome Sequencing Market Trends
        2.3.2 Cancer Genome Sequencing Market Drivers
        2.3.3 Cancer Genome Sequencing Market Challenges
        2.3.4 Cancer Genome Sequencing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cancer Genome Sequencing Players by Revenue
        3.1.1 Global Top Cancer Genome Sequencing Players by Revenue (2016-2021)
        3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2016-2021)
    3.2 Global Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cancer Genome Sequencing Revenue
    3.4 Global Cancer Genome Sequencing Market Concentration Ratio
        3.4.1 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Sequencing Revenue in 2020
    3.5 Cancer Genome Sequencing Key Players Head office and Area Served
    3.6 Key Players Cancer Genome Sequencing Product Solution and Service
    3.7 Date of Enter into Cancer Genome Sequencing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genome Sequencing Breakdown Data by Type
    4.1 Global Cancer Genome Sequencing Historic Market Size by Type (2016-2021)
    4.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027)

5 Cancer Genome Sequencing Breakdown Data by Application
    5.1 Global Cancer Genome Sequencing Historic Market Size by Application (2016-2021)
    5.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cancer Genome Sequencing Market Size (2016-2027)
    6.2 North America Cancer Genome Sequencing Market Size by Type
        6.2.1 North America Cancer Genome Sequencing Market Size by Type (2016-2021)
        6.2.2 North America Cancer Genome Sequencing Market Size by Type (2022-2027)
        6.2.3 North America Cancer Genome Sequencing Market Size by Type (2016-2027)
    6.3 North America Cancer Genome Sequencing Market Size by Application
        6.3.1 North America Cancer Genome Sequencing Market Size by Application (2016-2021)
        6.3.2 North America Cancer Genome Sequencing Market Size by Application (2022-2027)
        6.3.3 North America Cancer Genome Sequencing Market Size by Application (2016-2027)
    6.4 North America Cancer Genome Sequencing Market Size by Country
        6.4.1 North America Cancer Genome Sequencing Market Size by Country (2016-2021)
        6.4.2 North America Cancer Genome Sequencing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cancer Genome Sequencing Market Size (2016-2027)
    7.2 Europe Cancer Genome Sequencing Market Size by Type
        7.2.1 Europe Cancer Genome Sequencing Market Size by Type (2016-2021)
        7.2.2 Europe Cancer Genome Sequencing Market Size by Type (2022-2027)
        7.2.3 Europe Cancer Genome Sequencing Market Size by Type (2016-2027)
    7.3 Europe Cancer Genome Sequencing Market Size by Application
        7.3.1 Europe Cancer Genome Sequencing Market Size by Application (2016-2021)
        7.3.2 Europe Cancer Genome Sequencing Market Size by Application (2022-2027)
        7.3.3 Europe Cancer Genome Sequencing Market Size by Application (2016-2027)
    7.4 Europe Cancer Genome Sequencing Market Size by Country
        7.4.1 Europe Cancer Genome Sequencing Market Size by Country (2016-2021)
        7.4.2 Europe Cancer Genome Sequencing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cancer Genome Sequencing Market Size (2016-2027)
    8.2 Asia-Pacific Cancer Genome Sequencing Market Size by Type
        8.2.1 Asia-Pacific Cancer Genome Sequencing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cancer Genome Sequencing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cancer Genome Sequencing Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cancer Genome Sequencing Market Size by Application
        8.3.1 Asia-Pacific Cancer Genome Sequencing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cancer Genome Sequencing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cancer Genome Sequencing Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cancer Genome Sequencing Market Size by Region
        8.4.1 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cancer Genome Sequencing Market Size (2016-2027)
    9.2 Latin America Cancer Genome Sequencing Market Size by Type
        9.2.1 Latin America Cancer Genome Sequencing Market Size by Type (2016-2021)
        9.2.2 Latin America Cancer Genome Sequencing Market Size by Type (2022-2027)
        9.2.3 Latin America Cancer Genome Sequencing Market Size by Type (2016-2027)
    9.3 Latin America Cancer Genome Sequencing Market Size by Application
        9.3.1 Latin America Cancer Genome Sequencing Market Size by Application (2016-2021)
        9.3.2 Latin America Cancer Genome Sequencing Market Size by Application (2022-2027)
        9.3.3 Latin America Cancer Genome Sequencing Market Size by Application (2016-2027)
    9.4 Latin America Cancer Genome Sequencing Market Size by Country
        9.4.1 Latin America Cancer Genome Sequencing Market Size by Country (2016-2021)
        9.4.2 Latin America Cancer Genome Sequencing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cancer Genome Sequencing Market Size (2016-2027)
    10.2 Middle East & Africa Cancer Genome Sequencing Market Size by Type
        10.2.1 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cancer Genome Sequencing Market Size by Application
        10.3.1 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cancer Genome Sequencing Market Size by Country
        10.4.1 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Agilent Technologies
        11.1.1 Agilent Technologies Company Details
        11.1.2 Agilent Technologies Business Overview
        11.1.3 Agilent Technologies Cancer Genome Sequencing Introduction
        11.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.1.5 Agilent Technologies Recent Development
    11.2 GE Healthcare Life Sciences
        11.2.1 GE Healthcare Life Sciences Company Details
        11.2.2 GE Healthcare Life Sciences Business Overview
        11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Introduction
        11.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.2.5 GE Healthcare Life Sciences Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Cancer Genome Sequencing Introduction
        11.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.3.5 Johnson & Johnson Recent Development
    11.4 LI-COR Biosciences
        11.4.1 LI-COR Biosciences Company Details
        11.4.2 LI-COR Biosciences Business Overview
        11.4.3 LI-COR Biosciences Cancer Genome Sequencing Introduction
        11.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.4.5 LI-COR Biosciences Recent Development
    11.5 Abbott Laboratories
        11.5.1 Abbott Laboratories Company Details
        11.5.2 Abbott Laboratories Business Overview
        11.5.3 Abbott Laboratories Cancer Genome Sequencing Introduction
        11.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.5.5 Abbott Laboratories Recent Development
    11.6 Beckman Coulter
        11.6.1 Beckman Coulter Company Details
        11.6.2 Beckman Coulter Business Overview
        11.6.3 Beckman Coulter Cancer Genome Sequencing Introduction
        11.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.6.5 Beckman Coulter Recent Development
    11.7 Bayer
        11.7.1 Bayer Company Details
        11.7.2 Bayer Business Overview
        11.7.3 Bayer Cancer Genome Sequencing Introduction
        11.7.4 Bayer Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.7.5 Bayer Recent Development
    11.8 Hamilton Thorne Biosciences
        11.8.1 Hamilton Thorne Biosciences Company Details
        11.8.2 Hamilton Thorne Biosciences Business Overview
        11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Introduction
        11.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.8.5 Hamilton Thorne Biosciences Recent Development
    11.9 Integrated DNA Technologies
        11.9.1 Integrated DNA Technologies Company Details
        11.9.2 Integrated DNA Technologies Business Overview
        11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Introduction
        11.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.9.5 Integrated DNA Technologies Recent Development
    11.10 Microchip Biotechnologies
        11.10.1 Microchip Biotechnologies Company Details
        11.10.2 Microchip Biotechnologies Business Overview
        11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Introduction
        11.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.10.5 Microchip Biotechnologies Recent Development
    11.11 Myriad Genetics
        11.11.1 Myriad Genetics Company Details
        11.11.2 Myriad Genetics Business Overview
        11.11.3 Myriad Genetics Cancer Genome Sequencing Introduction
        11.11.4 Myriad Genetics Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.11.5 Myriad Genetics Recent Development
    11.12 Commonwealth Biotechnologies
        11.12.1 Commonwealth Biotechnologies Company Details
        11.12.2 Commonwealth Biotechnologies Business Overview
        11.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Introduction
        11.12.4 Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.12.5 Commonwealth Biotechnologies Recent Development
    11.13 ZS Genetics
        11.13.1 ZS Genetics Company Details
        11.13.2 ZS Genetics Business Overview
        11.13.3 ZS Genetics Cancer Genome Sequencing Introduction
        11.13.4 ZS Genetics Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.13.5 ZS Genetics Recent Development
    11.14 Pacific Biosciences
        11.14.1 Pacific Biosciences Company Details
        11.14.2 Pacific Biosciences Business Overview
        11.14.3 Pacific Biosciences Cancer Genome Sequencing Introduction
        11.14.4 Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021)
        11.14.5 Pacific Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cancer Genome Sequencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Second Generation
    Table 3. Key Players of Third Generation
    Table 4. Global Cancer Genome Sequencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Cancer Genome Sequencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Cancer Genome Sequencing Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Cancer Genome Sequencing Market Share by Regions (2016-2021)
    Table 8. Global Cancer Genome Sequencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Cancer Genome Sequencing Market Share by Regions (2022-2027)
    Table 10. Cancer Genome Sequencing Market Trends
    Table 11. Cancer Genome Sequencing Market Drivers
    Table 12. Cancer Genome Sequencing Market Challenges
    Table 13. Cancer Genome Sequencing Market Restraints
    Table 14. Global Cancer Genome Sequencing Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Cancer Genome Sequencing Market Share by Players (2016-2021)
    Table 16. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genome Sequencing as of 2020)
    Table 17. Ranking of Global Top Cancer Genome Sequencing Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Cancer Genome Sequencing Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Cancer Genome Sequencing Product Solution and Service
    Table 21. Date of Enter into Cancer Genome Sequencing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Cancer Genome Sequencing Revenue Market Share by Type (2016-2021)
    Table 25. Global Cancer Genome Sequencing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Cancer Genome Sequencing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Cancer Genome Sequencing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Cancer Genome Sequencing Revenue Market Share by Application (2016-2021)
    Table 29. Global Cancer Genome Sequencing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Cancer Genome Sequencing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Cancer Genome Sequencing Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Cancer Genome Sequencing Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Cancer Genome Sequencing Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Cancer Genome Sequencing Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Agilent Technologies Company Details
    Table 62. Agilent Technologies Business Overview
    Table 63. Agilent Technologies Cancer Genome Sequencing Product
    Table 64. Agilent Technologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 65. Agilent Technologies Recent Development
    Table 66. GE Healthcare Life Sciences Company Details
    Table 67. GE Healthcare Life Sciences Business Overview
    Table 68. GE Healthcare Life Sciences Cancer Genome Sequencing Product
    Table 69. GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 70. GE Healthcare Life Sciences Recent Development
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Cancer Genome Sequencing Product
    Table 74. Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 75. Johnson & Johnson Recent Development
    Table 76. LI-COR Biosciences Company Details
    Table 77. LI-COR Biosciences Business Overview
    Table 78. LI-COR Biosciences Cancer Genome Sequencing Product
    Table 79. LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 80. LI-COR Biosciences Recent Development
    Table 81. Abbott Laboratories Company Details
    Table 82. Abbott Laboratories Business Overview
    Table 83. Abbott Laboratories Cancer Genome Sequencing Product
    Table 84. Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 85. Abbott Laboratories Recent Development
    Table 86. Beckman Coulter Company Details
    Table 87. Beckman Coulter Business Overview
    Table 88. Beckman Coulter Cancer Genome Sequencing Product
    Table 89. Beckman Coulter Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 90. Beckman Coulter Recent Development
    Table 91. Bayer Company Details
    Table 92. Bayer Business Overview
    Table 93. Bayer Cancer Genome Sequencing Product
    Table 94. Bayer Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 95. Bayer Recent Development
    Table 96. Hamilton Thorne Biosciences Company Details
    Table 97. Hamilton Thorne Biosciences Business Overview
    Table 98. Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 99. Hamilton Thorne Biosciences Recent Development
    Table 100. Integrated DNA Technologies Company Details
    Table 101. Integrated DNA Technologies Business Overview
    Table 102. Integrated DNA Technologies Cancer Genome Sequencing Product
    Table 103. Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 104. Integrated DNA Technologies Recent Development
    Table 105. Microchip Biotechnologies Company Details
    Table 106. Microchip Biotechnologies Business Overview
    Table 107. Microchip Biotechnologies Cancer Genome Sequencing Product
    Table 108. Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 109. Microchip Biotechnologies Recent Development
    Table 110. Myriad Genetics Company Details
    Table 111. Myriad Genetics Business Overview
    Table 112. Myriad Genetics Cancer Genome Sequencing Product
    Table 113. Myriad Genetics Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 114. Myriad Genetics Recent Development
    Table 115. Commonwealth Biotechnologies Company Details
    Table 116. Commonwealth Biotechnologies Business Overview
    Table 117. Commonwealth Biotechnologies Cancer Genome Sequencing Product
    Table 118. Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 119. Commonwealth Biotechnologies Recent Development
    Table 120. ZS Genetics Company Details
    Table 121. ZS Genetics Business Overview
    Table 122. ZS Genetics Cancer Genome Sequencing Product
    Table 123. ZS Genetics Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 124. ZS Genetics Recent Development
    Table 125. Pacific Biosciences Company Details
    Table 126. Pacific Biosciences Business Overview
    Table 127. Pacific Biosciences Cancer Genome Sequencing Product
    Table 128. Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2016-2021) & (US$ Million)
    Table 129. Pacific Biosciences Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Genome Sequencing Market Share by Type: 2020 VS 2027
    Figure 2. Second Generation Features
    Figure 3. Third Generation Features
    Figure 4. Global Cancer Genome Sequencing Market Share by Application: 2020 VS 2027
    Figure 5. Treatment Case Studies
    Figure 6. Research Case Studies
    Figure 7. Cancer Genome Sequencing Report Years Considered
    Figure 8. Global Cancer Genome Sequencing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Cancer Genome Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Cancer Genome Sequencing Market Share by Regions: 2020 VS 2027
    Figure 11. Global Cancer Genome Sequencing Market Share by Regions (2022-2027)
    Figure 12. Global Cancer Genome Sequencing Market Share by Players in 2020
    Figure 13. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genome Sequencing as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2020
    Figure 15. Global Cancer Genome Sequencing Revenue Market Share by Type (2016-2021)
    Figure 16. Global Cancer Genome Sequencing Revenue Market Share by Type (2022-2027)
    Figure 17. North America Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Cancer Genome Sequencing Market Share by Type (2016-2027)
    Figure 19. North America Cancer Genome Sequencing Market Share by Application (2016-2027)
    Figure 20. North America Cancer Genome Sequencing Market Share by Country (2016-2027)
    Figure 21. United States Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Cancer Genome Sequencing Market Share by Type (2016-2027)
    Figure 25. Europe Cancer Genome Sequencing Market Share by Application (2016-2027)
    Figure 26. Europe Cancer Genome Sequencing Market Share by Country (2016-2027)
    Figure 27. Germany Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Cancer Genome Sequencing Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Cancer Genome Sequencing Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2016-2027)
    Figure 37. China Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Cancer Genome Sequencing Market Share by Type (2016-2027)
    Figure 45. Latin America Cancer Genome Sequencing Market Share by Application (2016-2027)
    Figure 46. Latin America Cancer Genome Sequencing Market Share by Country (2016-2027)
    Figure 47. Mexico Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Cancer Genome Sequencing Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Cancer Genome Sequencing Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Cancer Genome Sequencing Market Share by Country (2016-2027)
    Figure 53. Turkey Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Cancer Genome Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Agilent Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 57. GE Healthcare Life Sciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 59. LI-COR Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 61. Beckman Coulter Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 62. Bayer Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 63. Hamilton Thorne Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 64. Integrated DNA Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 65. Microchip Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 66. Myriad Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 67. Commonwealth Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 68. ZS Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 69. Pacific Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Frequently Asked Questions
Cancer Genome Sequencing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Genome Sequencing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Genome Sequencing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Car Finance

Car financing includes range of financial products that provide funds to customers to acquire a c ... Read More

Casino and Gaming

A casino is a place where a variety of games of chance are played and numerous types of gambling  ... Read More

Celiac Disease Drugs

Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumpti ... Read More